Each month, this advisory presents the best stock for the current market conditions. You will build a diversified portfolio of the best growth, momentum, value, international and dividend stocks for a very affordable price.
Tim Lutts is not only the Chief Analyst of Cabot Stock of the Month; he is also Cabot’s Chief Investment Strategist. This puts Tim in a unique position to select the most attractive stock from five Cabot advisories.
Cabot Stock of the Month recommends one stock each month from five other Cabot advisories, including value stocks, growth stocks, momentum stocks, dividend stocks and international stocks, depending on what appears to be the most promising stock for the current market conditions. The advisory does not present a model portfolio—i.e., there's no cash position, weightings, etc.; however, all recommendations are followed up weekly with buy, hold and eventually sell ratings. The performance shown is the average gain of Cabot Stock of the Month's current holdings, as of 10/30/15.
105% in Stryker
78% in Melco Crown Entertainment
72% in Express Scripts
69% in Salix Pharmaceuticals
Try Cabot Stock of the Month risk-free for 12 months.
What our Customers say about Cabot Stock of the Month
Hi Mr. Lutts, Thanks for a winner in Stryker (SYK), like others who watch your newsletters I had purchased Stryker on Cabot’s recommendation a while back and last night it hit my sell limit at 81. Nice profit for me and it will pay for more of your newsletters! I have told several friends and hopefully they will become subscribers too. Thanks again for your advice and sharing your knowledge.
Rob Rochelle, Charlotte, North Carolina
I am "blown away" by the value I receive from the Cabot group. You offer even more than promised. Kindest regards.
Sophia Z., Long Island City, New York
An easy way to invest without any worry.
D. Aston, Florence, Alabama
Are you ready to get started with your risk-free trial subscription?